Keywords
Newborn
Uruguay
How to Cite
Abstract
Introduction: trisomy 21 or Down Syndrome is the most frequent chromosomal alteration, with a general incidence of 1 in 600 to 800 live newborns. Diagnosis is based on clinical suspicion and cytogenetic confirmation. Congenital heart disease and gastrointestinal malformations are frequent, as are hematological abnormalities and thyroid disorders.
Materials and Methods: descriptive study with the objective of describing the phenotypic and genetic characteristics, malformations and associated morbidities in patients with trisomy 21 born in the neonatology service of the Pereira Rossell Hospital between July 1, 2017 and July 1, 2021.
Results: 56 patients were included, 30/56 were male, the mean gestational age was 37 weeks. A total of 17 patients were preterm. Of the patients studied, 45/56 presented free trisomy in the karyotype. Hypotonia was the most frequently observed sign on clinical examination. The most common birth defect, in 34 patients, was congenital heart disease. Among them, the most frequent defect was interatrial septal defect (CIA), followed by interventricular septal defect (VSD) and thirdly, atrioventricular canal (AV canal). Twenty-three patients with alterations in the complete blood count were found, being thrombocytopenia the most observed alteration. Nine patients were diagnosed with hypothyroidism and overall mortality during hospitalization was 1.78%.
Conclusions: we must highlight the high prevalence of prematurity and associated congenital defects, being congenital heart disease the most frequent.
References
Nussbaum R, McInnes R, Willard H. Thompson & Thompson: genética en medicina. 8 ed. Barcelona: Elsevier, 2016.
Martin R, Fanaroff A, Walsh M. Medicina neonatal y perinatal de Martin y Fanaroff. 10 ed. Medellín: Amolca, 2016.
Molina F. Métodos de cribado de aneuploidías en diagnóstico prenatal. Diagn Prenat 2011; 22(3):92-6.
Díaz S, Yokoyama E, Del Castillo V. Genómica del síndrome de Down. Acta Pediatr Méx 2016; 37(5):289-96.
Borbonet D, Mañé R. Defectos congénitos en el recién nacido. En: Pose Trujillo G, coord. Neonatología: temas prácticos. 2 ed. Montevideo: Vesalius, 2016:217-33.
Jones K. Down syndrome. En: Jones KL. Smith's recognizable patterns of human malformation. 6 ed. Philadelphia, PA: Elsevier-Saunders, 2006:7.
Kolgeci S, Kolgeci J, Azemi M, Shala R, Gashi Z, Sopjani M. Cytogenetic study in children with down syndrome among kosova Albanian population between 2000 and 2010. Mater Sociomed 2013; 25(2):131-5. doi: 10.5455/msm.2013.25.131-135.
Hübner E, Ramírez R, Nazer J. Malformaciones congénitas: diagnóstico y manejo neonatal. 2 ed. Santiago de Chile: Mediterráneo, 2016:20-33.
Luna B, Taboada G, Rada A, Lafuente E, Burgos J, Luna R, et al. Diagnóstico prenatal integral en Síndrome de Down en La Paz, Bolivia, correlación sérica, ecográfica, citogenética y molecular: a propósito de un caso. Rev Méd La Paz 2014; 20(2):47-9.
García J, Palanca D, Domínguez M, Madurga P. Comunicación interauricular (CIA). Comunicación Interventricular (CIV). En: Redondo S, Segura S, Sánchez A, González J, eds. Cuidados críticos de niño con patología cardíaca. Madrid: Ergon, 2018:101-12.
Síndrome de Down, número monográfico. Rev Esp Pediatr Clin Investig 2012; 68(6). Disponible en: https://www.sindromedown.net/wp-content/uploads/2014/09/122L_revista.pdf. (Consulta: 15 junio 2022).
Andrés M, Fernández B, Fernández R. Alteraciones hematológicas en las personas con síndrome de Down. Rev Esp Pediatr 2012, 68(6):421-3.
Dixon N, Kishnani P, Zimmerman S. Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome. Am J Med Genet C Semin Med Genet 2006; 142C(3):149-57. doi: 10.1002/ajmg.c.30096.
Larrandaburu M. Caracterização das anomalias congênitas no uruguai do século xxi: avaliação das necessidades de saúde. Porto Alegre-RS: Universidade Federal Do Rio Grande Do Sul; Instituto de biociência de pós-graduação em genética e biologia molecular, 2018.
Moraes M, Pereda M, Belo S, Bueno F, Calvelo A, De Los Santos M, et al. Mortalidad y enfermedades asociadas al síndrome de Down en el primer año de vida: experiencia de la Policlínica Interdisciplinaria de Atención al Niño con Síndrome de Down del Servicio de Recién Nacidos del Centro Hospitalario Pereira Rossell. Arch Pediatr Urug 2007; 78(3):204-8.
Weijerman M, van Furth A, Vonk A, van Wouwe J, Broers C, Gemke R. Prevalence, neonatal characteristics, and first-year mortality of Down syndrome: a national study. J Pediatr 2008; 152(1):15-9. doi: 10.1016/j.jpeds.2007.09.045.
Nakousi N, Cares C, Alegría A, Gaínza M, López L, Gayan A, et al. Anomalías congénitas y comorbilidad en neonatos con Síndrome de Down. Rev Chil Pediatr 2020; 91(5):732-42. doi: 10.32641/rchped.vi91i5.1518.
Martini J, Bindodo M, Duarte S, Liascovich R, Barbero P, Groisman B. Prevalencia del síndrome de Down al nacimiento en Argentina. Salud Colect 2019; 15. doi: 10.18294/sc.2019.1863.
Shin M, Siffel C, Correa A. Survival of children with mosaic Down syndrome. Am J Med Genet A 2010; 152A(3):800-1. doi: 10.1002/ajmg.a.33295.
Hall B. Mongolism in newborn infants. An examination of the criteria for recognition and some speculations on the pathogenic activity of the chromosomal abnormality. Clin Pediatr (Phila) 1966; 5(1):4-12. doi: 10.1177/000992286600500102.
Heinke D, Isenburg J, Stallings E, Short T, Le M, Fisher S, et al. Prevalence of structural birth defects among infants with Down syndrome, 2013-2017: A US population-based study. Birth Defects Res 2021; 113(2):189-202. doi: 10.1002/bdr2.1854.
Freeman S, Taft L, Dooley K, Allran K, Sherman S, Hassold T, et al. Population-based study of congenital heart defects in Down syndrome. Am J Med Genet 1998; 80(3):213-7.
Irving C, Chaudhari M. Cardiovascular abnormalities in Down's syndrome: spectrum, management and survival over 22 years. Arch Dis Child 2012; 97(4):326-30. doi: 10.1136/adc.2010.210534.
Kivivuori S, Rajantie J, Siimes M. Peripheral blood cell counts in infants with Down's syndrome. Clin Genet 1996; 49(1):15-9. doi: 10.1111/j.1399-0004.1996.tb04318.x.
Widness J, Pueschel S, Pezzullo J, Clemons G. Elevated erythropoietin levels in cord blood of newborns with Down's syndrome. Biol Neonate 1994; 66(1):50-5. doi: 10.1159/000244089.
Karlsson B, Gustafsson J, Hedov G, Ivarsson S, Annerén G. Thyroid dysfunction in Down's syndrome: relation to age and thyroid autoimmunity. Arch Dis Child 1998; 79(3):242-5. doi: 10.1136/adc.79.3.242.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2024 Vanina Silva, Camila Piquerez, Álvaro Dendi, Helena Sobrero, Mario Moraes